Asa Botanicals is proudly representing our new CBG-only products: CBG Oil & CBG Capsules. This article aims to inform you of the amazing findings there are for CBG, and what purposes it has.
A Different Cannabinoid?
In the past couple of years, accessible knowledge, research, and excitement has all begun to show for cannabidiol (CBD), but as our other articles may have told you, there are over one hundred different cannabinoids in medical cannabis. So, why is it that CBD and THC get all of the attention?
From a scientific perspective, there is actually a third cannabinoid that carries out essential functions, so essential that the others simply can’t exist without.
There is an abundance of different cannabinoids in the family tree, and a vast majority of them actually perform similar functions. However, cannabigerol, or CBG, is often labeled as the “mother cannabinoid.”
What is CBG?
The mother cannabinoid is the parent cannabinoid that is eventually stemmed from all other synthesized cannabinoids. CBG is similar to CBD in a few ways. The first being that it’s also non-psychoactive, so it won’t produce a “high.” Also, it is still processed in the endocannabinoid system, so many parts of the body can be affected through CB1 receptors, most abundantly found in the brain.
Studies show that when cannabinoids latch onto these receptors, homeostasis can occur for multiple bodily functions. CBG has been shown to be a neuroprotective agent, appetite stimulant, antibacterial agent, a serotonin inhibitor (antidepressant) and possible glaucoma treatment.
CBG is considered a minor cannabinoid because it usually only composes 1% of the cannabinoids. However, breeders are continuously improving ways to increase this count because of several studied benefits.
What We’re Finding
Researchers are finding that CBG is a powerful appetite stimulant. In this study, researchers gave CBG or a placebo to lab rats, and aimed to find what effect it had on motor function. Not only did it have no adverse effect on motor ability, but they found that 120-240 mg of CBG doubled their food intake and reduced latency to feed, even though meal sizes never changed. This is strong evidence to support CBG as an agent for those with cachexia (excessive weight loss.) A referenced study also found that CBG produced anandamide, which is known to drive appetite.
Anandamide is the body’s natural “bliss” endocannabinoid. It’s not in anxiolytic medications, but one study found that blocking the inhibitor for anandamide produced anxiolytic-like effects without any behavioral effects brought on by THC. CBG has consistently been shown as a producer of this bliss chemical.
Cannabis has long been labeled as a possible treatment for glaucoma, but many of the medical strains possess cannabinoids that actually can increase intraocular pressure, thus worsening any symptoms over time. Luckily, CBG is the cannabinoid that is believed to do the opposite. By lowering intraocular pressure, the chances of developing glaucoma are much much lower. The study aimed to compare the effects of CBG and THC. The study first gave a topical dosage to cats’ eyes and found a noticeable, but minimal change in intraocular pressure. However, once chronic administration directly to the eye through minipumps, a statistically significant fall decrease in pressure occurred. THC, on the other hand, created temporary polyspike discharges, which did go away over time. Once the cannabinoids were taken away, they produced two-to three-fold in aqueous outflow, thus supporting CBG as a possible glaucoma treatment.
CBG is believed to fight some forms of cancer as well. One study discovered how CBG may be able to treat colon cancer. First off, the study found that CBG directly targets proteins and other neurological channels that may cause carcinogenesis (cancer formation.) The study concluded that CBG promoted apoptosis (cell death) in cancerous tumors, reduced cell growth in colorectal cancer. Notably, CBG’s cell growth effect was independent of natural cancerous combatants. CBG also inhibited the growth of xenograft tumors, as well as chemically induced colon cancers.
A large focus of cannabinoid studies revolves around Huntington’s Disease (HD) or Alzheimer’s. This is because multiple studies have shown how CBD has neuroprotective qualities, even with diabetic neuropathy. In one study published in the NCBI found CBG as an “extremely” active neuroprotectant in mice intoxicated with 3NP (HD induced). The mice had improvement with motor deficits and preserving neurons against 3NP toxicity. They also found that CBG improved levels of antioxidant defenses, which are also critically reduced by 3NP.
Cannabinoids have an extremely complex system. Most of them work well when together, while some work when isolated for specific ailments. However, the synergistic effect brought on by the family of cannabinoids isn’t something to ignore. CBG is often a minor component in oils because of how much is composed in the pool of cannabinoids, but this will change over time.
CBG oil absolutely serves its purpose, with its own functionality and desired benefits. Research is taking notice of the many other cannabinoids’ influence, and not just CBD.
If you’re interested in trying CBG for yourself, then visit our Store!
*Disclaimer* We are in no way saying CBG/CBD cures any of the ailments listed above. The scope of this article was to inform. As we cannot give any medical advice, consult your physician before trying CBG/CBD, especially if you take other medications.